Copyright © Inderes 2011 - present. All rights reserved.

Bioretec

0.03 EUR

-14.86 %

1,735 following
Corporate customer

BRETEC

First North Finland

Medical Equipment & Services

Health Care

-14.86 %
+83.40 %
-46.24 %
-54.30 %
-81.22 %
-86.99 %
-89.70 %
-
-90.27 %

Bioretec operates in the medical technology sector. The company specializes in the development of medical technology products. The product portfolio includes, for example, implants for pediatric and adult orthopedics and other materials for bone and soft tissue injuries. In addition to the main business, service and related ancillary services are also offered. The business is operated globally with the largest presence in the Nordic region.

Read more
Market cap
38.02M EUR
Turnover
5.44K EUR
P/E (adj.) (26e)
-4.11
EV/EBIT (adj.) (26e)
-3.54
P/B (26e)
2.45
EV/S (26e)
6.56
Dividend yield-% (26e)
-
Coverage
Recommendation
Accumulate
Target price
0.02 EUR
Updated
30.03.2026
Disclaimer
Antti Siltanen
Antti Siltanen

Analyst

Latest research

Latest analysis report

Released: 30.03.2026

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
8.5
2026

General meeting '26

15.5
2026

Business review Q1'26

13.8
2026

Interim report Q2'26

Risk
Business risk
Valuation risk
Low
High
ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Forum discussions
It’s rare to be able to give investment advice, but in this case, one almost dares to suggest: sell the old ones for three cents and buy new ones for a cent.
10 hours ago
by Critter
5
You’ve been able to sell them all along since the subscription right split off as its own instrument. By selling immediately, you would have gotten about seven cents for a security worth roughly one cent. Even now, it’s almost 3.
10 hours ago
by Expaco_b
4
And right away there was an announcement of management transactions Inderes Bioretec Oy - Johdon liiketoimet - Stephen Industries Inc Oy - Inderes Bioretec Oy Yhtiötiedote 15.4.2026 klo 12:00 Bioretec Oy - Johdon liiketoimet____________________________________________IlmoitusvelvollinenNim...
yesterday
by Critter
3
Apparently Stephen’s subscription was already known, but it’s been quiet regarding the others. You’d think the CEO, for example, earns a high enough salary that they would have bought subscription rights with some amount and used them to subscribe.
yesterday
by Roni
2
Even management has no confidence in the company, since they haven’t bought anything Management holdings | Bioretec
yesterday
by Roni
2
Could someone more knowledgeable tell me, as I don’t quite understand how this works. If I have subscribed to the new shares and they are visible in my portfolio, can I already sell the old shares without any impact on the new ones?
10 hours ago
by TuuriSeilaaja
1
Couldn’t a procedure performed with Bioretec’s screw be priced high enough that the costs are close to the cost of two traditional operations? Additionally, the patient has an easier time since only one surgical procedure is required. Quality and convenience come at a price.
yesterday
by Index
1
Read more on our forum
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.